000 02352 a2200601 4500
005 20250516180615.0
264 0 _c20140815
008 201408s 0 0 eng d
022 _a1536-4828
024 7 _a10.1097/MPA.0b013e3182a6486e
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrandi, Giovanni
245 0 0 _aAntiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
_h[electronic resource]
260 _bPancreas
_cJan 2014
300 _a53-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBlotting, Western
650 0 4 _aCell Line
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aExtracellular Signal-Regulated MAP Kinases
_xmetabolism
650 0 4 _aGabexate
_xadministration & dosage
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInterleukin-8
_xgenetics
650 0 4 _aMatrix Metalloproteinase 2
_xgenetics
650 0 4 _aMatrix Metalloproteinase 9
_xgenetics
650 0 4 _aNF-kappa B
_xantagonists & inhibitors
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSerine Proteinase Inhibitors
_xadministration & dosage
650 0 4 _aVascular Endothelial Growth Factor A
_xgenetics
650 0 4 _aGemcitabine
700 1 _aTavolari, Simona
700 1 _aGuarnieri, Tiziana
700 1 _aDi Marco, Mariacristina
700 1 _aPaterini, Paola
700 1 _aMacchini, Marina
700 1 _aDi Girolamo, Stefania
700 1 _aPapi, Alessio
700 1 _aDe Rosa, Francesco
700 1 _aBiasco, Guido
773 0 _tPancreas
_gvol. 43
_gno. 1
_gp. 53-63
856 4 0 _uhttps://doi.org/10.1097/MPA.0b013e3182a6486e
_zAvailable from publisher's website
999 _c23240698
_d23240698